The Effect of Glucocorticoids on Bone Profile in Pediatric Acute Lymphoblastic Leukemia

Authors

DOI:

https://doi.org/10.37287/ijghr.v8i1.229

Keywords:

acute lymphoblastic leukemia, bone profile, glucocorticoid, magnesium

Abstract

Glucocorticoids are essential in treating acute lymphoblastic leukemia (ALL) but may disrupt bone metabolism, affecting calcium, magnesium, phosphate, and alkaline phosphatase levels. This cross-sectional study enrolled 30 children ≤18 years with ALL at Adam Malik Hospital, Medan, during April–May 2025 using consecutive sampling. All had received at least one week of glucocorticoid therapy and had complete bone profile data. Data were obtained from medical records and laboratory tests. Associations were analyzed using Spearman’s correlation, Mann-Whitney test, and multiple linear regression. Most patients were male (53.3%) and classified as high-risk (60%), with 60% receiving dexamethasone for a median of 7 weeks. Calcium, phosphate, and alkaline phosphatase levels were generally within the normal range, but 50% of patients developed hypermagnesemia. Magnesium levels were significantly associated with the type of glucocorticoid (p=0.010), treatment duration (p=0.014), and age at diagnosis (p=0.006). No significant associations were found between glucocorticoid duration and calcium, phosphate, or alkaline phosphatase levels. Magnesium levels are influenced by glucocorticoid type, treatment duration, and age at diagnosis. Further studies with larger samples and additional biomarkers are needed to comprehensively understand the effects of glucocorticoids on the bone profile of children.

References

Kaplan JA. Leukemia in children. Pediatr Rev. 2019;40(7):319–329. doi:10.1542/pir.2018-0249

Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020;395:1146–1162. doi:10.1016/S0140-6736(20)30308-3

Brown P, Inaba H, Annesley C, et al. Pediatric acute lymphoblastic leukemia, Version 2.2020. J Natl Compr Canc Netw. 2020;18(1):81–112. doi:10.6004/jnccn.2020.0002

Wijayanti LP, Supriyadi E. The prognostic factors and survival of pediatric acute lymphoblastic leukemia patients in Dr. Sardjito Hospital, Yogyakarta, 2010–2015. J Pediatr Hematol Oncol. 2017;39(10):15–22. doi:10.1097/MPH.0000000000000873

Garniasih D, Susanah S, Sribudiani Y, Hilmanto D. The incidence and mortality of childhood acute lymphoblastic leukemia in Indonesia: A systematic review and meta-analysis. PLoS ONE. 2022;17(6):e0269389. doi:10.1371/journal.pone.0269389

Pourhassan H, Murphy L, Aldoss I. Glucocorticoid therapy in acute lymphoblastic leukemia: Navigating short-term and long-term effects and optimal regimen selection. Curr Hematol Malig Rep. 2024;1:449–457. doi:10.1007/s11899-024-00786-1

Hunger SP. Glucocorticoid selection for pediatric ALL. Blood. 2016;127(17):2049–2051. doi:10.1182/blood-2016-01-634257

Hua J, Huang J, Li G, Lin S, Cui L. Glucocorticoid induced bone disorders in children: Research progress in treatment mechanisms. Front Endocrinol. 2023;14:1–10. doi:10.3389/fendo.2023.1070192

Velentza L, Zaman F, Sävendahl L, et al. Bone health in glucocorticoid-treated childhood acute lymphoblastic leukemia. Crit Rev Oncol Hematol. 2021;168:103543. doi:10.1016/j.critrevonc.2021.103543

Li SY, Ye JY, Meng FY, Li CF, Yang M. Clinical characteristics of acute lymphoblastic leukemia in male and female patients: A retrospective analysis of 705 patients. Oncol Lett. 2015;10(1):453–458. doi:10.3892/ol.2015.3262

Supriyadi E, Widjajanto PH, Purwanto I, Cloos J, Veerman AJP, Sutaryo S. Incidence of childhood leukemia in Yogyakarta, Indonesia, 1998–2009. Pediatr Blood Cancer. 2011;57(4):588–593. doi:10.1002/pbc.22963

Afridi HI, Kazi TG, Talpur FN. Correlation of calcium and magnesium levels in the biological samples of different types of acute leukemia children. Biol Trace Elem Res. 2018;186(2):395–406. doi:10.1007/s12011-018-1375-0

Atkinson SA, Fraher L, Gundberg CM, Andrew M, Pai M, Barr RD. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr. 1989;114(4):744–750. doi:10.1016/S0022-3476(89)80438-0

Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003;24(2):47–66.

Cascella M, Vaqar S. Hypermagnesemia [Internet]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 [updated 2023 Jun 4; cited 2025 Jul 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549811/

Inaba H, Pui CH. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol. 2010;11(11):1096–1106. doi:10.1016/S1470-2045(10)70192-5

Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, Dawson S, et al. Altered mineral metabolism and bone mass during treatment for acute lymphoblastic leukemia in children. J Bone Miner Res. 1996;11(11):1774–1783. doi:10.1002/jbmr.5650111112

Santoso MC, Windiastuti E, Tumbelaka AR. The proportion of bone mineral density in children with high-risk acute lymphoblastic leukemia after 6- and 12-month chemotherapy maintenance phase. Paediatr Indones. 2010;50(6):351–356. doi:10.14238/pi50.6.2010.351-6

Bordbar MR, Haghpanah S, Dabbaghmanesh MH, Omrani GR, Saki F. Bone mineral density in children with acute leukemia and its associated factors in Iran: a case-control study. Arch Osteoporos. 2016;11(1):24. doi:10.1007/s11657-016-0272-4

Kobza AO, Herman D, Papaioannou A, Lau AN, Adachi JD. Understanding and managing corticosteroid-induced osteoporosis. Open Access Rheumatol. 2021;13:177–190. doi:10.2147/OARRR.S312838

Ardissone P, Rota E, Durelli L, Limone P, Isaia GC. Effects of high doses of corticosteroids on bone metabolism. J Endocrinol Invest. 2002;25(2):129–133. doi:10.1007/BF03343976

Soliman ASA, Abukhatwah MW, Kamal NM, Sweed EMM, Alelyani AM, Althobaiti SD, et al. Bone densitometry in children with idiopathic nephrotic syndrome on prolonged steroid therapy: A tertiary multicenter study. Medicine (Baltimore). 2022;101(33):e29860. doi:10.1097/MD.0000000000029860

Ahmed SF, Tucker P, Mushtaq T, Wallace AM, Williams DM, Hughes IA. Short term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone. Clin Endocrinol (Oxf). 2002;57(2):185–191. doi:10.1046/j.1365-2265.2002.01679.x

Das S, Meena RK, Shah D, Almeida EA, Mehndiratta M, Gupta P. Children with severe acute malnutrition have high rates of bone resorption: A cross-sectional comparative study. Nutrition Research. 2023;117:66–72. doi:10.1016/j.nutres.2023.05.002

Picáns-Leis R, Nieto F, Romero-Agrelo A, Izquierdo-López I, Rivas-Rodríguez L, Vázquez-Cobela R, et al. Impact of acute lymphoblastic leukaemia treatment on the nutritional status of paediatric patients: a systematic review. Nutrients. 2024;16(1):4119. doi:10.3390/nu16124119.

Downloads

Published

2026-02-28

How to Cite

Prajogo, P., Lubis, B., Lubis, S. M., Fujiati, I. I., Sembiring, T., & Abdillah, H. Z. (2026). The Effect of Glucocorticoids on Bone Profile in Pediatric Acute Lymphoblastic Leukemia. Indonesian Journal of Global Health Research, 8(1), 1155–1160. https://doi.org/10.37287/ijghr.v8i1.229

Similar Articles

<< < 1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.